Reference
Mori Y. [Ruxolitinib for treatment of GvHD in patients with myelofibrosis]. Rinsho Ketsueki 60: 953-959, No. 8, 2019. Available from: URL: http://doi.org/10.11406/rinketsu.60.953 - Japan
Rights and permissions
About this article
Cite this article
Antithymocyte globulin/ruxolitinib. Reactions Weekly 1777, 38 (2019). https://doi.org/10.1007/s40278-019-70622-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70622-y